David Ciccone

3.2k total citations
20 papers, 2.1k citations indexed

About

David Ciccone is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, David Ciccone has authored 20 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in David Ciccone's work include Genomics and Chromatin Dynamics (7 papers), DNA Repair Mechanisms (4 papers) and Epigenetics and DNA Methylation (4 papers). David Ciccone is often cited by papers focused on Genomics and Chromatin Dynamics (7 papers), DNA Repair Mechanisms (4 papers) and Epigenetics and DNA Methylation (4 papers). David Ciccone collaborates with scholars based in United States, United Kingdom and China. David Ciccone's co-authors include Marjorie A. Oettinger, Katrina B. Morshead, David M. Livingston, Kevin Struhl, Huck‐Hui Ng, Taiping Chen, Frédérique Gay, Jeffrey Bajko, Hui Su and Guoliang Xu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David Ciccone

17 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ciccone United States 10 1.9k 358 354 329 297 20 2.1k
Igor Chernukhin United Kingdom 23 1.4k 0.7× 393 1.1× 184 0.5× 165 0.5× 358 1.2× 44 1.8k
Miriam Fuchs United States 10 1.7k 0.9× 419 1.2× 208 0.6× 152 0.5× 339 1.1× 10 2.0k
Hank H. Qi United States 16 1.9k 1.0× 203 0.6× 214 0.6× 546 1.7× 291 1.0× 21 2.2k
Robert K. Slany Germany 33 3.1k 1.7× 304 0.8× 210 0.6× 198 0.6× 205 0.7× 68 3.6k
Bernhard Lehnertz Canada 16 1.6k 0.9× 137 0.4× 181 0.5× 93 0.3× 299 1.0× 24 2.0k
Rupert Öllinger Germany 20 745 0.4× 347 1.0× 285 0.8× 114 0.3× 145 0.5× 45 1.3k
Stephen B. Baylin United States 6 1.4k 0.8× 307 0.9× 93 0.3× 320 1.0× 265 0.9× 6 1.7k
Karen E. Hunter United States 7 576 0.3× 520 1.5× 404 1.1× 356 1.1× 150 0.5× 8 1.3k
Diana Low Singapore 14 1.4k 0.7× 186 0.5× 161 0.5× 183 0.6× 185 0.6× 18 1.7k
Hauke Cornils Switzerland 13 1.3k 0.7× 287 0.8× 119 0.3× 343 1.0× 228 0.8× 15 1.8k

Countries citing papers authored by David Ciccone

Since Specialization
Citations

This map shows the geographic impact of David Ciccone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ciccone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ciccone more than expected).

Fields of papers citing papers by David Ciccone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ciccone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ciccone. The network helps show where David Ciccone may publish in the future.

Co-authorship network of co-authors of David Ciccone

This figure shows the co-authorship network connecting the top 25 collaborators of David Ciccone. A scholar is included among the top collaborators of David Ciccone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ciccone. David Ciccone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciccone, David, Scott Boiko, Samantha Carreiro, et al.. (2025). Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 13(7). e012064–e012064.
2.
Ciccone, David, Scott Boiko, Scott R. Daigle, et al.. (2023). 1340 NDI-101150 is a potent and highly selective hematopoietic progenitor kinase 1 (HPK1) inhibitor that promotes a robust and broad anti-tumor immune response. SHILAP Revista de lepidopterología. A1494–A1494. 1 indexed citations
3.
Leit, Silvana, David L. Laughton, Suzanne L. Jacques, et al.. (2022). Abstract 589: Discovery of NTX-001, a potent Cbl-b inhibitor with antitumor activity in syngeneic models. Cancer Research. 82(12_Supplement). 589–589. 1 indexed citations
4.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2021). Abstract 1649: Mechanistic understanding of HPK1 inhibition on enhanced human T cell activation and tumor immunity in a syngeneic model. Cancer Research. 81(13_Supplement). 1649–1649. 1 indexed citations
5.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. SHILAP Revista de lepidopterología. A411.1–A411. 1 indexed citations
6.
Ciccone, David, Ian D. Linney, Michael A. Briggs, et al.. (2020). A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model. European Journal of Cancer. 138. S20–S20. 1 indexed citations
7.
Ciccone, David, Jennifer L. Rocnik, Ian D. Linney, et al.. (2020). Abstract 942: HPK1, hematopoietic progenitor kinase 1, is a promising therapeutic target for cancer immunotherapy. Cancer Research. 80(16_Supplement). 942–942.
8.
Ciccone, David, Yuka Namiki, Katrina B. Morshead, et al.. (2019). The murine IgH locus contains a distinct DNA sequence motif for the chromatin regulatory factor CTCF. Journal of Biological Chemistry. 294(37). 13580–13592. 6 indexed citations
9.
Martin, Francis J., Yong Xu, Felix Lohmann, et al.. (2015). KMT1E-mediated chromatin modifications at the FcγRIIb promoter regulate thymocyte development. Genes and Immunity. 16(2). 162–169. 12 indexed citations
10.
11.
Ciccone, David, Hui Su, Sarah Hevi, et al.. (2009). KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature. 461(7262). 415–418. 378 indexed citations
12.
Ciccone, David & Taiping Chen. (2009). Histone lysine methylation in genomic imprinting. Epigenetics. 4(4). 216–220. 15 indexed citations
13.
Matthews, Adam G. W., Alex Kuo, Santiago Ramón‐Maiques, et al.. (2007). RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 450(7172). 1106–1110. 363 indexed citations
14.
Ciccone, David & Marjorie A. Oettinger. (2004). Chromatin Modifications as Clues to the Regulation of Antigen Receptor Assembly. Novartis Foundation symposium. 259. 146–162. 1 indexed citations
15.
Ciccone, David, Katrina B. Morshead, & Marjorie A. Oettinger. (2003). Chromatin Immunoprecipitation in the Analysis of Large Chromatin Domains Across Murine Antigen Receptor Loci. Methods in enzymology on CD-ROM/Methods in enzymology. 376. 334–348. 23 indexed citations
16.
Morshead, Katrina B., David Ciccone, Sean D. Taverna, C. David Allis, & Marjorie A. Oettinger. (2003). Antigen receptor loci poised for V(D)J rearrangement are broadly associated with BRG1 and flanked by peaks of histone H3 dimethylated at lysine 4. Proceedings of the National Academy of Sciences. 100(20). 11577–11582. 157 indexed citations
17.
Ng, Huck‐Hui, David Ciccone, Katrina B. Morshead, Marjorie A. Oettinger, & Kevin Struhl. (2003). Lysine-79 of histone H3 is hypomethylated at silenced loci in yeast and mammalian cells: A potential mechanism for position-effect variegation. Proceedings of the National Academy of Sciences. 100(4). 1820–1825. 258 indexed citations
18.
Bassing, Craig H., Katrin F. Chua, JoAnn Sekiguchi, et al.. (2002). Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proceedings of the National Academy of Sciences. 99(12). 8173–8178. 450 indexed citations
19.
Ranganathan, Velvizhi, Walter Heine, David Ciccone, et al.. (2001). Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Current Biology. 11(12). 962–966. 94 indexed citations
20.
Wu, Xiaohua, Velvizhi Ranganathan, David Weisman, et al.. (2000). ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature. 405(6785). 477–482. 372 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Igor Chernukhin Breakdown of academic impact, for papers by Miriam Fuchs Breakdown of academic impact, for papers by Hank H. Qi Breakdown of academic impact, for papers by Robert K. Slany Breakdown of academic impact, for papers by Bernhard Lehnertz Breakdown of academic impact, for papers by Rupert Öllinger Breakdown of academic impact, for papers by Stephen B. Baylin Breakdown of academic impact, for papers by Karen E. Hunter Breakdown of academic impact, for papers by Diana Low Breakdown of academic impact, for papers by Hauke Cornils
Rankless by CCL
2026